aTyr Pharma Q3 EPS $(1.47) Beats $(1.73) Estimate, Sales $184K Beat $60K Estimate

aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(1.47) per share which beat the analyst consensus estimate of $(1.73) by 15.03 percent. This is a 512.5 percent decrease over losses of $(0.24) per share from the

Benzinga · 11/14/2019 21:06

aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(1.47) per share which beat the analyst consensus estimate of $(1.73) by 15.03 percent. This is a 512.5 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $184 thousand which beat the analyst consensus estimate of $60 thousand by 206.67 percent.